☆ 4.6 Review

The Therapeutic Potential of Amphetamine-like Psychostimulants

LIFE-BASEL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Psychology, Clinical

Auditory discrimination and frequency modulation learning in schizophrenia patients: amphetamine within-subject dose response and time course

Neal R. Swerdlow et al.

Summary: The study investigated the dose and time-course effects of the pro-attentional drug amphetamine on auditory learning in schizophrenia patients. The results showed that amphetamine improved auditory processing and attention performance, especially in patients with low MCCB attention/vigilance scores.

PSYCHOLOGICAL MEDICINE (2023)

添加到收藏夹

Article Medicine, General & Internal

Mixed Amphetamine Salts Without a Mood Stabilizer for Treating Comorbid Attention-Deficit Hyperactivity Disorder and Bipolar Disorder: Two Case Reports

Cody Armstrong et al.

Summary: ADHD and BD often coexist in patients and have overlapping symptoms. Standard treatment is mood stabilizer with possible addition of psychostimulant, but research on using psychostimulant alone for comorbid disorders is lacking. Here, we present two cases where traditionally avoided mixed amphetamine salts effectively treated comorbid BD and ADHD without a mood stabilizer, highlighting the need for further investigations.

MILITARY MEDICINE (2023)

添加到收藏夹

Article Pediatrics

Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day

Stephen V. V. Faraone et al.

Summary: This study evaluated the treatment effect size of amphetamine extended-release oral suspension in children with ADHD throughout the day. The results showed that the medication had a large and consistent effect size, especially in the early morning.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2023)

添加到收藏夹

Review Neurosciences

Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder

Damian Koevoet et al.

Summary: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social impairments and repetitive behaviors. Treatment of ASD is difficult and could benefit from understanding the underlying mechanisms shared with other disorders, such as attention-deficit hyperactivity disorder (ADHD). Deficiencies in dopamine and norepinephrine in ADHD are potential targets for stimulant treatment, and recent findings suggest that dysfunction in these systems may also be involved in ASD. This review analyzes the evidence for catecholaminergic mechanisms in ASD and explores potential interventions targeting these systems, as well as the acetylcholinergic network. The review also suggests that stimulant treatment may be a viable option for certain ASD subgroups, cerebellar dysfunction may indicate a need for interventions targeting NE or ACh, and deficiency in the cortical salience network may be involved in both ASD and ADHD.

FRONTIERS IN NEUROSCIENCE (2023)

添加到收藏夹

Review Clinical Neurology

Adult Attention-Deficit/Hyperactivity Disorder: a Narrative Review of Biological Mechanisms, Treatments, and Outcomes

Antonio F. Pagan et al.

Summary: This review article discusses the biological mechanisms, clinical manifestations, treatments, and outcomes of adult ADHD, as well as the current controversies within the field. Recent research has identified white matter disruptions in multiple cortical pathways in adults with ADHD. New treatments and research findings show promising potential in improving the quality of life and outcomes for individuals with this chronic health condition.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2023)

添加到收藏夹

Article Pediatrics

d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivotal Trial

Andrew J. Cutler et al.

Summary: This study provides additional evidence on the efficacy and safety of d-ATS in the treatment of ADHD, with significant improvement observed in ADHD symptoms. The effect size and number needed to treat (NNT) suggest that d-ATS is a clinically meaningful treatment option for ADHD patients.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2023)

添加到收藏夹

Article Pediatrics

Lisdexamphetamine as a novel therapy for hyperphagia in Prader-Willi syndrome

John Preddy et al.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2023)

添加到收藏夹

Article Immunology

Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions

Samuele Laudani et al.

Summary: Mounting evidence suggests a link between gut microbiota abnormalities and PTSD, but the influence of gut microbiota on PTSD susceptibility is poorly understood. This study demonstrates pre-trauma and post-trauma gut microbiota alterations in susceptible mice with persistent PTSD-related phenotypes. The findings suggest that gut microbiota abnormalities contribute to trauma susceptibility and could be a potential therapeutic target for PTSD.

BRAIN BEHAVIOR AND IMMUNITY (2023)

添加到收藏夹

Article Substance Abuse

Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study

Hamzah Bakouni et al.

Summary: This study aimed to explore the impact of doses of buprenorphine/naloxone (BUP-NX) and methadone on the effectiveness and safety of treating non-heroin opioid use disorder (OUD). The results showed that methadone dose was associated with higher treatment retention, while BUP-NX dose was not.

AMERICAN JOURNAL ON ADDICTIONS (2023)

添加到收藏夹

Article Substance Abuse

The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD

Christopher R. Nicholas et al.

Summary: This analysis explores the effects of MDMA-assisted therapy (MDMA-AT) on alcohol and substance use in patients with severe post-traumatic stress disorder (PTSD). The results show that MDMA-AT is associated with a significant reduction in alcohol use but does not appear to have an impact on drug use. These findings provide preliminary evidence for the development of MDMA-AT as an integrated treatment for PTSD and ASUD.

DRUG AND ALCOHOL DEPENDENCE (2022)

添加到收藏夹

Article Psychology, Developmental

Causal effects of psychostimulants on neural connectivity: a mechanistic, randomized clinical trial

Yun Wang et al.

Summary: The therapeutic effects of psychostimulants in treating ADHD are associated with changes in dynamic functional connectivity rather than static functional connectivity. This finding may have important implications for the development of new ADHD interventions.

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2022)

添加到收藏夹

Article Pediatrics

A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder

Ann C. Childress et al.

Summary: This study evaluated the long-term safety and tolerability of lisdexamfetamine dimesylate (LDX) in preschool-aged children (4-5 years old) with attention-deficit/hyperactivity disorder (ADHD). The results showed that the optimized dosage of LDX (5-30 mg) was well tolerated and led to reductions in ADHD symptoms compared to baseline.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults

Jessica L. Maples-Keller et al.

Summary: This study investigated the effects of MDMA on fear learning, extinction training, and retention in healthy humans. Although the hypothesized facilitation of extinction retention was not observed, the findings from this initial human trial provide compelling rationale to continue exploring the potential impact of MDMA on extinction retention.

JOURNAL OF PSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Psychology, Developmental

Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder

Ann C. Childress et al.

Summary: This study evaluated the acute efficacy, safety, and tolerability of lisdexamfetamine dimesylate (LDX) vs placebo (PBO) in preschool-aged children with attention-deficit/hyperactivity disorder (ADHD). LDX was found to be more effective than PBO in reducing symptoms and was generally well tolerated.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2022)

添加到收藏夹

Article Medicine, General & Internal

Effect of Phentermine on Hepatic Steatosis in Bariatric Surgery: A Pilot Study

Elizabeth Perez-Cruz et al.

Summary: This study found that phentermine reduced the frequency of hepatic steatosis and promoted greater reduction in fat mass in patients undergoing bariatric surgery. This suggests that phentermine may help reduce the risk of complications in bariatric surgery.

MEDICAL PRINCIPLES AND PRACTICE (2022)

添加到收藏夹

Review Environmental Sciences

An Update on the Implications of New Psychoactive Substances in Public Health

Ana Y. Simao et al.

Summary: The emergence of new psychoactive substances, particularly synthetic opiates, has attracted significant attention due to reports of acute poisoning and deaths. In recent years, there have been notable changes in legislation related to the consumption, marketing, and synthesis of these compounds. Rapid alert systems have also undergone modifications, and new substances and markets, primarily through the internet, have emerged. Little is known about the effects and origins of these substances in consumers, particularly in terms of chronic toxicity. This review aims to provide a comprehensive description of these substances, focusing on consumption, toxicokinetics, and health consequences, including case reports of intoxications, to assist researchers and public health agents in their daily work.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal

Liam S. Acheson et al.

Summary: This is the first study to assess lisdexamfetamine for the treatment of acute MA withdrawal. If safe and feasible results will go to informing the development of multi-centre randomised controlled trials to determine the efficacy of the intervention.

PLOS ONE (2022)

添加到收藏夹

Article Substance Abuse

Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial

Liam S. Acheson et al.

Summary: This study recruited 10 adult male patients with a median age of 37.1 years and utilized a tapering dose regimen of lisdexamfetamine to treat withdrawal symptoms. The results showed that this treatment approach was safe, feasible, and effective in reducing withdrawal symptoms and cravings.

DRUG AND ALCOHOL DEPENDENCE (2022)

添加到收藏夹

Article Psychology, Clinical

Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder

Linnae Ponte et al.

Summary: This study demonstrates the beneficial effects of MDMA-assisted psychotherapy in improving sleep quality and reducing symptoms in individuals with PTSD during treatment.

JOURNAL OF TRAUMATIC STRESS (2021)

添加到收藏夹

Article Substance Abuse

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report

Heather Palis et al.

Summary: This study presents the first report of prescribing dextroamphetamine for the treatment of stimulant use disorder to a patient receiving injectable opioid agonist treatment outside of a clinical trial. After 4 weeks of treatment, the patient successfully reduced cocaine use with good medication tolerance. The case demonstrates the potential for dextroamphetamine to support patients in reducing or stopping their cocaine use, especially in settings where regular contact with care is available.

HARM REDUCTION JOURNAL (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Therapeutic Potential of Psilocybin

Henry Lowe et al.

Summary: The psychedelic effects of certain plants and fungi have been intentionally utilized by humans for religious and spiritual purposes for centuries, with mushrooms serving as a primary source of naturally occurring psychedelics. Amidst negative stigma associated with psychedelic use, the U.S. government classified psychedelics as Schedule 1 drugs in 1970, impeding scientific research progress. Recent studies on the therapeutic potential of psilocybin in treating neuropsychiatric conditions have reignited interest and efforts in psilocybin research, leading to significant advances in understanding its chemical properties and uses.

MOLECULES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Jennifer M. Mitchell et al.

Summary: The results demonstrate that MDMA-assisted therapy is safe and effective in treating severe post-traumatic stress disorder. Compared with placebo, MDMA significantly reduces CAPS-5 scores and improves functional impairment.

NATURE MEDICINE (2021)

添加到收藏夹

Article Health Policy & Services

Problem-Focused Psychodynamic Psychotherapies

Fredric N. Busch

Summary: In recent years, manualized psychodynamic approaches have been developed to target specific problems or disorders and are used for systematic outcome studies. One example, panic-focused psychodynamic psychotherapy, has shown efficacy in treating panic disorder. These manuals are designed to be easily understood for training purposes and can be more readily applied in the public health sector. Extensive research is needed to determine the most effective psychotherapies for different patients and conditions.

PSYCHIATRIC SERVICES (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study

Nadine Ezard et al.

Summary: The study aimed to examine the safety of lisdexamfetamine (LDX) treatment at 250mg/day among adults with methamphetamine (MA) dependence. Results showed that participants tolerated LDX at a dose of up to 250mg/day well and experienced a decrease in the number of days using MA during the withdrawal period.

BMJ OPEN (2021)

添加到收藏夹

Article Psychology, Clinical

Open-label pilot study of lisdexamfetamine for cocaine use disorder

John J. Mariani et al.

Summary: The study of lisdexamfetamine for treating CUD demonstrated that it is safe and generally well tolerated at doses up to 140 mg daily, and can effectively reduce the number of days of cocaine use and daily expenditure on cocaine.

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2021)

添加到收藏夹

Article Psychiatry

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial

Alan K. Davis et al.

Summary: The study showed that psilocybin therapy with psychological support is effective in treating MDD, building on previous findings in patients with cancer and depression, as well as in a nonrandomized study in patients with treatment-resistant depression.

JAMA PSYCHIATRY (2021)

添加到收藏夹

Article Neurosciences

Brief history of the medical and non-medical use of amphetamine-like psychostimulants

Micaela Morelli et al.

Summary: Ephedrine, derived from Ephedra vulgaris, is the origin of psychostimulant drugs like amphetamine, which were initially used for medical treatments but saw a decrease in utilization since the 1970s due to recognized high risk of addiction and abuse. Originally used as anti-asthmatics and to combat narcolepsy, their recreational stimulant and anorexic effects were later reported. The use of selective amphetamine-like drugs nowadays is limited to treating ADHD.

EXPERIMENTAL NEUROLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Three- and six-month efficacy and safety of phentermine in a Mexican obese population

Maribel Marquez-Cruz et al.

Summary: The study found that 30 mg of phentermine was more effective than 15 mg after 3 months, but the difference was not significant after 6 months of treatment. A substantial number of subjects could benefit from the therapy between 3 and 6 months.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2021)

添加到收藏夹

Article Psychiatry

Working memory, cortical dopamine tone, and frontoparietal brain recruitment in post-traumatic stress disorder: a randomized controlled trial

Andrew J. Westphal et al.

Summary: Based on a pharmacological functional magnetic resonance imaging study, increasing cortical dopamine tone may help improve working memory performance in individuals with more severe PTSD symptoms, potentially serving as a promising approach to remediating cognitive and affective dysfunction.

TRANSLATIONAL PSYCHIATRY (2021)

添加到收藏夹

Article Psychology, Developmental

A Long-Term, Open-Label, Safety Study of Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD

Lenard A. Adler et al.

JOURNAL OF ATTENTION DISORDERS (2020)

添加到收藏夹

Article Psychology, Developmental

Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD: Results of a Phase 3, Double-Blind, Randomized, Forced-Dose Trial

Glen Frick et al.

JOURNAL OF ATTENTION DISORDERS (2020)

添加到收藏夹

Article Substance Abuse

Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial

Peter Blanken et al.

ADDICTION (2020)

添加到收藏夹

Review Psychiatry

Psychedelics and Psychedelic-Assisted Psychotherapy

Collin M. Reiff et al.

AMERICAN JOURNAL OF PSYCHIATRY (2020)

添加到收藏夹

Review Neurosciences

The role of catecholamines in modulating responses to stress: Sex-specific patterns, implications, and therapeutic potential for post-traumatic stress disorder and opiate withdrawal

Jennifer A. Ross et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2020)

添加到收藏夹

Article Pediatrics

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder

Ann C. Childress et al.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Primary Care Providers' Perspectives on Prescribing Antidepressant Medication to Latino Immigrant Patients A Preliminary Study

Laura Kirkpatrick et al.

JOURNAL OF NERVOUS AND MENTAL DISEASE (2020)

添加到收藏夹

Review Medicine, General & Internal

Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders A Systematic Review and Meta-analysis

Lara A. Ray et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Neurosciences

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials

Lisa Jerome et al.

PSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials

Ana Sofia Vargas et al.

BIOMEDICINES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study

Philip E. Wolfson et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Medicine, Research & Experimental

An adaptive clinical trial design for cocaine use disorder: Extended-release amphetamine salts for early behavioral intervention non-responders

Derek Blevins et al.

CONTEMPORARY CLINICAL TRIALS (2020)

添加到收藏夹

Article Psychology, Clinical

Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder

Ingmar Gorman et al.

JOURNAL OF TRAUMATIC STRESS (2020)

添加到收藏夹

Review Psychology, Clinical

Psychedelic-Assisted Group Therapy: A Systematic Review

Alexander Trope et al.

JOURNAL OF PSYCHOACTIVE DRUGS (2019)

添加到收藏夹

Review Psychiatry

Yoga for posttraumatic stress disorder - a systematic review and meta-analysis

Holger Cramer et al.

BMC PSYCHIATRY (2018)

添加到收藏夹

Review Neurosciences

MDMA and PTSD treatment PTSD: From novel pathophysiology to innovative therapeutics

Ben Sessa

NEUROSCIENCE LETTERS (2017)

添加到收藏夹

Review Clinical Neurology

Evidence-Based Psychotherapy: Advantages and Challenges

Sarah C. Cook et al.

NEUROTHERAPEUTICS (2017)

添加到收藏夹

Review Rheumatology

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain

Jarred Younger et al.

CLINICAL RHEUMATOLOGY (2014)

添加到收藏夹

Review Pharmacology & Pharmacy

Amphetamine-Type Medicines: A Review of Pharmacokinetics, Pharmacodynamics, and Toxicological Aspects

Kristianee C. Mariotti et al.

CURRENT CLINICAL PHARMACOLOGY (2013)

添加到收藏夹

Review Toxicology

Toxicity of amphetamines: an update

Marcia Carvalho et al.

ARCHIVES OF TOXICOLOGY (2012)

添加到收藏夹

Article Medical Laboratory Technology

Toxicokinetics of amphetamines: Metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives

T Kraemer et al.

THERAPEUTIC DRUG MONITORING (2002)

添加到收藏夹

Article Chemistry, Analytical

Amphetamine, clobenzorex, and 4-hydroxyclobenzorex levels following multidose administration of clobenzorex

JT Cody et al.

JOURNAL OF ANALYTICAL TOXICOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.